Flexible and stretchable bioelectronics inform cardiac health

Scilight ◽  
2022 ◽  
Vol 2022 (2) ◽  
pp. 021107
Author(s):  
Ashley Piccone
Keyword(s):  
2021 ◽  
Vol 79 ◽  
pp. 109889
Author(s):  
Lily S. Neff ◽  
Amy D. Bradshaw

Autophagy ◽  
2019 ◽  
Vol 16 (10) ◽  
pp. 1807-1822 ◽  
Author(s):  
Kai Chang ◽  
Ping Kang ◽  
Ying Liu ◽  
Kerui Huang ◽  
Ting Miao ◽  
...  

2021 ◽  
Vol 77 (18) ◽  
pp. 1482
Author(s):  
Kimberly Uehisa ◽  
Timothy Samuelson ◽  
Marcella Calfon-Press ◽  
Tamara Horwich ◽  
Karol Watson ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Claire Richards ◽  
Kimberly Sesperez ◽  
Michael Chhor ◽  
Sahar Ghorbanpour ◽  
Claire Rennie ◽  
...  

Abstract Background Preeclampsia is a dangerous cardiovascular disorder of pregnancy that leads to an increased risk of future cardiovascular and metabolic disorders. Much of the pathogenesis and mechanisms involved in cardiac health in preeclampsia are unknown. A novel anti-angiogenic protein, FKBPL, is emerging as having a potential role in both preeclampsia and cardiovascular disease (CVD). Therefore, in this study we aimed to characterise cardiac health and FKBPL regulation in the rat reduced uterine perfusion pressure (RUPP) and a 3D cardiac spheroid model of preeclampsia. Methods The RUPP model was induced in pregnant rats and histological analysis performed on the heart, kidney, liver and placenta (n ≥ 6). Picrosirius red staining was performed to quantify collagen I and III deposition in rat hearts, placentae and livers as an indicator of fibrosis. RT-qPCR was used to determine changes in Fkbpl, Icam1, Vcam1, Flt1 and Vegfa mRNA in hearts and/or placentae and ELISA to evaluate cardiac brain natriuretic peptide (BNP45) and FKBPL secretion. Immunofluorescent staining was also conducted to analyse the expression of cardiac FKBPL. Cardiac spheroids were generated using human cardiac fibroblasts and human coronary artery endothelial cells and treated with patient plasma from normotensive controls, early-onset preeclampsia (EOPE) and late-onset preeclampsia (LOPE); n = 3. FKBPL and CD31 expression was quantified by immunofluorescent labelling. Results The RUPP procedure induced significant increases in blood pressure (p < 0.001), collagen deposition (p < 0.001) and cardiac BNP45 (p < 0.05). It also induced a significant increase in cardiac FKBPL mRNA (p < 0.05) and protein  expression  (p < 0.01). RUPP placentae also exhibited increased collagen deposition and decreased Flt1 mRNA expression (p < 0.05). RUPP kidneys revealed an increase in average glomerular size (p < 0.05). Cardiac spheroids showed a significant increase in FKBPL expression when treated with LOPE plasma (p < 0.05) and a trend towards increased FKBPL expression following treatment with EOPE plasma (p = 0.06). Conclusions The rat RUPP model induced cardiac, renal and placental features reflective of preeclampsia. FKBPL was increased in the hearts of RUPP rats and cardiac spheroids treated with plasma from women with preeclampsia, perhaps reflective of restricted angiogenesis and inflammation in this disorder. Elucidation of these novel FKBPL mechanisms in cardiac health in preeclampsia could be key in preventing future CVD.


ITBM-RBM ◽  
2005 ◽  
Vol 26 (2) ◽  
pp. 133-139 ◽  
Author(s):  
Rajendra Acharya U. ◽  
P. Subbanna Bhat ◽  
N. Kannathal ◽  
Ashok Rao ◽  
Choo Min Lim

2014 ◽  
Vol 5 ◽  
Author(s):  
Eleonora Grandi ◽  
Andrew G. Edwards ◽  
Anthony W. Herren ◽  
Donald M. Bers

Computer ◽  
2016 ◽  
Vol 49 (11) ◽  
pp. 38-48 ◽  
Author(s):  
Shurouq Hijazi ◽  
Alex Page ◽  
Burak Kantarci ◽  
Tolga Soyata

1987 ◽  
Vol 1 (1) ◽  
pp. 23-31 ◽  
Author(s):  
John G. MAEland ◽  
Odd E. Havik

2021 ◽  
Vol 7 (1) ◽  
pp. 1-6
Author(s):  
Sultan Alasmari ◽  
Mohammed Makkawi ◽  
Mutaib M Mashraqi ◽  
Saleh Alqahtani ◽  
Mustafa Alqahtani ◽  
...  

Coronavirus disease-2019 (COVID-19) is an infectious disease that has spread worldwide and led to ongoing global concern. The pandemic prompted researchers to examine the impact of COVID-19 on human organs. The heart is one such organ. This study investigates the possible prediction of heart condition using some biochemical markers of particularly critically ill patients referred to an intensive care unit (ICU). Results of various serum biomarkers of patients infected with COVID-19 receiving treatment in the ICU, Asir Central Hospital, Asir Region, Saudi Arabia, were extracted and compared with healthy individuals using the Mann-Whitney U test. The study showed a distinguished increase in total Serum creatine phosphokinase-Total (CPK-Total), Serum creatine phosphokinase-MP (CPK-MP) levels among COVID-19/ICU patients. But, this increase was not statistically significant. Besides, aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase levels revealed a statistically significant increase in the infected group compared with controls. Examination of electrolytes showed a reduction in calcium median value in COVID-19/ICU patients. Data revealed a possible influence of COVID-19 on the heart. Herein, we observe significant parameters that may reflect cardiovascular injury elicited by the virus. These biomarkers possibly used to monitor the severity of disease on the cardiovascular system.


Sign in / Sign up

Export Citation Format

Share Document